Certified by the best age management medical boards in the industry.
Studies on periodontal disease models show the peptide significantly reduced plasma extravasation, histological alterations, and alveolar bone resorption
In the DELTA 1 and DELTA 2 phase 3 trials, delgocitinib cream (20 mg/g) applied twice daily significantly significantly improved IGA-CHE scores compared with vehicle, with 19.729.1% of patients achieving clear or almost clear skin, respectively, versus 6.99.9% in the vehicle groups [103, 106]
Gallery[] For a full gallery featuring promo images, packaging, and videos see Tamagotchi (1996 Pet)/Gallery
Compound-Level Evidence GHK-Cu A 2018 review in the International Journal of Molecular Sciences synthesized gene-expression data showing GHK-Cu modulates over 4,000 human genes (Pickart and Margolina)